Skip to main content
. Author manuscript; available in PMC: 2010 Mar 4.
Published in final edited form as: Vaccine. 2009 Jan 23;27(10):1549–1556. doi: 10.1016/j.vaccine.2009.01.010

Figure 6.

Figure 6

Protein array analysis of antibody responses to a panel of vaccinia antigens. Plasma samples were obtained from vaccinated monkeys at week 13 following priming immunizations with either rVV or rMVA and tested at a 1:250 dilution against the indicated protein antigens by ELISA. VIG was used as a positive control (20 μg/ml). The baculovirus-produced A27L, A33R, B5R, and L1R recombinant proteins used in the standard ELISA assays described in Figure 5 were included as positive controls, and are shown in the last four rows separated from the main array. Data are presented as response at 4 weeks following subtraction of the response from matched pre-immune plasma. Background responses were consistently below 0.04, a response of 0.05-0.1 was considered borderline and a response above 0.1 as positive. Mean replicate variation was 2.1% +/- 2.3%.